With the decreasing uptake of well-known influenza and COVID-19 vaccines, leaders of the U.S. Food and Drug Administration (FDA) recently published an insightful editorial regarding the future of virology in the United States.
Published by The JAMA Network on January 5, 2024, Peter Marks, MD, PhD, and Robert Califf, MD wrote a Viewpoint titled: Is Vaccination Approaching a Dangerous Tipping Point?
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
